The Blavatnik Biomedical Accelerator is now accepting applications for funding beginning in July 2020.

Apply now for grants of $100K–$300K to advance innovative research with clear commercial potential.

Benefits

• Access to consultants and 100+ contract research organizations
• Strategic advising from Harvard OTD
• Achieve scientific milestones relevant to industry

Track record

• $20M in grants to 113 projects
• Major license agreements
• 16 new companies launched, $500M+ raised in equity financing
• $40M in new industry research funding

Eligibility

All principal investigators employed by Harvard University who assign intellectual property rights to Harvard.

For full details, view the RFP, and for further information, please contact .(JavaScript must be enabled to view this email address).